20 May 2013
Keywords: zonagen, gets, irb, appro, ph, iii, androxal
Article | 16 January 2006
US drugmaker Zonagen has received Investigational Review Board approval for the start of its Phase III study of Androxal, a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 January 2006
17 May 2013
© 2013 thepharmaletter.com